 | • レポートコード：MRC2-11QY08408 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は経口固形剤形（OSDF）・医薬品添加剤のグローバル市場について調査・分析したレポートです。種類別（グリセリン、プロピレングリコール、ソルビトール、マンニトール、その他）市場規模、用途別（工業用、非工業用）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別経口固形剤形（OSDF）・医薬品添加剤の競争状況、市場シェア ・世界の経口固形剤形（OSDF）・医薬品添加剤市場：種類別市場規模 2015年-2020年（グリセリン、プロピレングリコール、ソルビトール、マンニトール、その他） ・世界の経口固形剤形（OSDF）・医薬品添加剤市場：種類別市場規模予測 2021年-2026年（グリセリン、プロピレングリコール、ソルビトール、マンニトール、その他） ・世界の経口固形剤形（OSDF）・医薬品添加剤市場：用途別市場規模 2015年-2020年（工業用、非工業用） ・世界の経口固形剤形（OSDF）・医薬品添加剤市場：用途別市場規模予測 2021年-2026年（工業用、非工業用） ・北米の経口固形剤形（OSDF）・医薬品添加剤市場分析：米国、カナダ ・ヨーロッパの経口固形剤形（OSDF）・医薬品添加剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの経口固形剤形（OSDF）・医薬品添加剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の経口固形剤形（OSDF）・医薬品添加剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの経口固形剤形（OSDF）・医薬品添加剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：ABITEC Corporation、AkzoNobel、Archer Daniels Midland (ADM)、BASF、DowDuPont、Evonik、J.M. Huber Corporation、Cargill、Eastman Chemical Company ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market
The global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Scope and Market Size
Oral Solid Dosage Forms (OSDF) and Pharma Excipients market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Solid Dosage Forms (OSDF) and Pharma Excipients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oral Solid Dosage Forms (OSDF) and Pharma Excipients market is segmented into
Glycerin
Propylene Glycol
Sorbitol
Mannitol
Others
Segment by Application, the Oral Solid Dosage Forms (OSDF) and Pharma Excipients market is segmented into
Industrial Application
Non-industrial Application
Regional and Country-level Analysis
The Oral Solid Dosage Forms (OSDF) and Pharma Excipients market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oral Solid Dosage Forms (OSDF) and Pharma Excipients market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share Analysis
Oral Solid Dosage Forms (OSDF) and Pharma Excipients market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Solid Dosage Forms (OSDF) and Pharma Excipients business, the date to enter into the Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, Oral Solid Dosage Forms (OSDF) and Pharma Excipients product introduction, recent developments, etc.
The major vendors covered:
ABITEC Corporation
AkzoNobel
Archer Daniels Midland (ADM)
BASF
DowDuPont
Evonik
J.M. Huber Corporation
Cargill
Eastman Chemical Company
1 Study Coverage
1.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Introduction
1.2 Market Segments
1.3 Key Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Growth Rate by Type
1.4.2 Glycerin
1.4.3 Propylene Glycol
1.4.4 Sorbitol
1.4.5 Mannitol
1.4.6 Others
1.5 Market by Application
1.5.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Growth Rate by Application
1.5.2 Industrial Application
1.5.3 Non-industrial Application
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size, Estimates and Forecasts
2.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue 2015-2026
2.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales 2015-2026
2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Competitor Landscape by Players
3.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Manufacturers
3.1.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Manufacturers (2015-2020)
3.1.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Manufacturers (2015-2020)
3.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Manufacturers
3.2.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Manufacturers (2015-2020)
3.2.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue in 2019
3.2.5 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Manufacturers
3.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturing Base Distribution, Product Types
3.4.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Type
3.4.3 Date of International Manufacturers Enter into Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Type (2015-2020)
4.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2015-2020)
4.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2015-2020)
4.1.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Forecast by Type (2021-2026)
4.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Type (2021-2026)
4.2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Type (2021-2026)
4.2.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Application (2015-2020)
5.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2015-2020)
5.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2015-2020)
5.1.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Application (2015-2020)
5.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Forecast by Application (2021-2026)
5.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Application (2021-2026)
5.2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Application (2021-2026)
5.2.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price Forecast by Application (2021-2026)
6 North America
6.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Country
6.1.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country
6.1.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Facts & Figures by Type
6.3 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Facts & Figures by Application
7 Europe
7.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Country
7.1.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country
7.1.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Facts & Figures by Type
7.3 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Region
8.1.1 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region
8.1.2 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Facts & Figures by Type
8.3 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Facts & Figures by Application
9 Latin America
9.1 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Country
9.1.1 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country
9.1.2 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Facts & Figures by Type
9.3 Central & South America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Country
10.1.1 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country
10.1.2 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Facts & Figures by Type
10.3 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Facts & Figures by Application
11 Company Profiles
11.1 ABITEC Corporation
11.1.1 ABITEC Corporation Corporation Information
11.1.2 ABITEC Corporation Description and Business Overview
11.1.3 ABITEC Corporation Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
11.1.5 ABITEC Corporation Related Developments
11.2 AkzoNobel
11.2.1 AkzoNobel Corporation Information
11.2.2 AkzoNobel Description and Business Overview
11.2.3 AkzoNobel Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
11.2.5 AkzoNobel Related Developments
11.3 Archer Daniels Midland (ADM)
11.3.1 Archer Daniels Midland (ADM) Corporation Information
11.3.2 Archer Daniels Midland (ADM) Description and Business Overview
11.3.3 Archer Daniels Midland (ADM) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
11.3.5 Archer Daniels Midland (ADM) Related Developments
11.4 BASF
11.4.1 BASF Corporation Information
11.4.2 BASF Description and Business Overview
11.4.3 BASF Sales, Revenue and Gross Margin (2015-2020)
11.4.4 BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
11.4.5 BASF Related Developments
11.5 DowDuPont
11.5.1 DowDuPont Corporation Information
11.5.2 DowDuPont Description and Business Overview
11.5.3 DowDuPont Sales, Revenue and Gross Margin (2015-2020)
11.5.4 DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
11.5.5 DowDuPont Related Developments
11.6 Evonik
11.6.1 Evonik Corporation Information
11.6.2 Evonik Description and Business Overview
11.6.3 Evonik Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
11.6.5 Evonik Related Developments
11.7 J.M. Huber Corporation
11.7.1 J.M. Huber Corporation Corporation Information
11.7.2 J.M. Huber Corporation Description and Business Overview
11.7.3 J.M. Huber Corporation Sales, Revenue and Gross Margin (2015-2020)
11.7.4 J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
11.7.5 J.M. Huber Corporation Related Developments
11.8 Cargill
11.8.1 Cargill Corporation Information
11.8.2 Cargill Description and Business Overview
11.8.3 Cargill Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
11.8.5 Cargill Related Developments
11.9 Eastman Chemical Company
11.9.1 Eastman Chemical Company Corporation Information
11.9.2 Eastman Chemical Company Description and Business Overview
11.9.3 Eastman Chemical Company Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
11.9.5 Eastman Chemical Company Related Developments
11.1 ABITEC Corporation
11.1.1 ABITEC Corporation Corporation Information
11.1.2 ABITEC Corporation Description and Business Overview
11.1.3 ABITEC Corporation Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
11.1.5 ABITEC Corporation Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Estimates and Projections by Region
12.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Regions 2021-2026
12.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Regions 2021-2026
12.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Forecast (2021-2026)
12.2.1 North America: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast (2021-2026)
12.2.2 North America: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast (2021-2026)
12.2.3 North America: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Forecast by Country (2021-2026)
12.3 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Forecast (2021-2026)
12.3.1 Europe: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast (2021-2026)
12.3.2 Europe: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast (2021-2026)
12.3.3 Europe: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Forecast by Region (2021-2026)
12.5 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Forecast (2021-2026)
12.5.1 Latin America: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast (2021-2026)
12.5.2 Latin America: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast (2021-2026)
12.5.3 Latin America: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oral Solid Dosage Forms (OSDF) and Pharma Excipients Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Segments
Table 2. Ranking of Global Top Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Glycerin
Table 5. Major Manufacturers of Propylene Glycol
Table 6. Major Manufacturers of Sorbitol
Table 7. Major Manufacturers of Mannitol
Table 8. Major Manufacturers of Others
Table 9. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Regions 2015-2020 (K Units)
Table 12. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Regions (2015-2020)
Table 13. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Manufacturers (2015-2020)
Table 16. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Solid Dosage Forms (OSDF) and Pharma Excipients as of 2019)
Table 18. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price (2015-2020) (USD/Unit)
Table 21. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Type
Table 23. Date of International Manufacturers Enter into Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2015-2020) (K Units)
Table 26. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Type (2015-2020)
Table 27. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Type (2015-2020)
Table 29. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2015-2020) (K Units)
Table 31. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Application (2015-2020)
Table 32. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2015-2020) (K Units)
Table 33. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country (2015-2020)
Table 34. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country (2015-2020)
Table 36. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2015-2020) (K Units)
Table 37. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2015-2020)
Table 38. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2015-2020) (K Units)
Table 39. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2015-2020)
Table 40. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2015-2020) (K Units)
Table 41. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country (2015-2020)
Table 42. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country (2015-2020)
Table 44. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2015-2020) (K Units)
Table 45. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2015-2020)
Table 46. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2015-2020) (K Units)
Table 47. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2015-2020) (K Units)
Table 49. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2015-2020) (K Units)
Table 53. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2015-2020) (K Units)
Table 55. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2015-2020)
Table 56. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2015-2020) (K Units)
Table 57. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country (2015-2020)
Table 60. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2015-2020) (K Units)
Table 61. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2015-2020)
Table 62. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2015-2020) (K Units)
Table 63. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2015-2020) (K Units)
Table 65. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2015-2020) (K Units)
Table 69. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2015-2020) (K Units)
Table 71. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2015-2020)
Table 72. ABITEC Corporation Corporation Information
Table 73. ABITEC Corporation Description and Major Businesses
Table 74. ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 75. ABITEC Corporation Product
Table 76. ABITEC Corporation Recent Development
Table 77. AkzoNobel Corporation Information
Table 78. AkzoNobel Description and Major Businesses
Table 79. AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. AkzoNobel Product
Table 81. AkzoNobel Recent Development
Table 82. Archer Daniels Midland (ADM) Corporation Information
Table 83. Archer Daniels Midland (ADM) Description and Major Businesses
Table 84. Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Archer Daniels Midland (ADM) Product
Table 86. Archer Daniels Midland (ADM) Recent Development
Table 87. BASF Corporation Information
Table 88. BASF Description and Major Businesses
Table 89. BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. BASF Product
Table 91. BASF Recent Development
Table 92. DowDuPont Corporation Information
Table 93. DowDuPont Description and Major Businesses
Table 94. DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. DowDuPont Product
Table 96. DowDuPont Recent Development
Table 97. Evonik Corporation Information
Table 98. Evonik Description and Major Businesses
Table 99. Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Evonik Product
Table 101. Evonik Recent Development
Table 102. J.M. Huber Corporation Corporation Information
Table 103. J.M. Huber Corporation Description and Major Businesses
Table 104. J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. J.M. Huber Corporation Product
Table 106. J.M. Huber Corporation Recent Development
Table 107. Cargill Corporation Information
Table 108. Cargill Description and Major Businesses
Table 109. Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Cargill Product
Table 111. Cargill Recent Development
Table 112. Eastman Chemical Company Corporation Information
Table 113. Eastman Chemical Company Description and Major Businesses
Table 114. Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. Eastman Chemical Company Product
Table 116. Eastman Chemical Company Recent Development
Table 117. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Regions (2021-2026) (K Units)
Table 118. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share Forecast by Regions (2021-2026)
Table 119. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 120. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share Forecast by Regions (2021-2026)
Table 121. North America: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Country (2021-2026) (K Units)
Table 122. North America: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Europe: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Country (2021-2026) (K Units)
Table 124. Europe: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Asia Pacific: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Region (2021-2026) (K Units)
Table 126. Asia Pacific: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Region (2021-2026) (US$ Million)
Table 127. Latin America: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Country (2021-2026) (K Units)
Table 128. Latin America: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Middle East and Africa: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Country (2021-2026) (K Units)
Table 130. Middle East and Africa: Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 132. Key Challenges
Table 133. Market Risks
Table 134. Main Points Interviewed from Key Oral Solid Dosage Forms (OSDF) and Pharma Excipients Players
Table 135. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Customers List
Table 136. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Distributors List
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Picture
Figure 2. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type in 2020 & 2026
Figure 3. Glycerin Product Picture
Figure 4. Propylene Glycol Product Picture
Figure 5. Sorbitol Product Picture
Figure 6. Mannitol Product Picture
Figure 7. Others Product Picture
Figure 8. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application in 2020 & 2026
Figure 9. Industrial Application
Figure 10. Non-industrial Application
Figure 11. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Report Years Considered
Figure 12. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size 2015-2026 (US$ Million)
Figure 13. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales 2015-2026 (K Units)
Figure 14. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Region (2015-2020)
Figure 16. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Region in 2019
Figure 17. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Region (2015-2020)
Figure 18. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Region in 2019
Figure 19. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue in 2019
Figure 21. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2015-2020)
Figure 23. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type in 2019
Figure 24. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Type (2015-2020)
Figure 25. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Type in 2019
Figure 26. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Price Range (2015-2020)
Figure 27. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2015-2020)
Figure 28. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application in 2019
Figure 29. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Application (2015-2020)
Figure 30. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Application in 2019
Figure 31. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country in 2019
Figure 34. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country in 2019
Figure 35. U.S. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Type in 2019
Figure 40. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Application in 2019
Figure 41. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country in 2019
Figure 44. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country in 2019
Figure 45. Germany Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Type in 2019
Figure 56. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Application in 2019
Figure 57. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Region in 2019
Figure 60. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Region in 2019
Figure 61. China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Type in 2019
Figure 84. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Application in 2019
Figure 85. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country in 2019
Figure 88. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country in 2019
Figure 89. Mexico Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Type in 2019
Figure 96. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Application in 2019
Figure 97. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country in 2019
Figure 101. Turkey Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Type in 2019
Figure 108. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Application in 2019
Figure 109. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
OSDF溶解度向上賦形剤の世界市場（～2026年） An excipient is a substance formulated alongside the active ingredient of a medication, included for the purpose of long-term stabilization, bulking up solid formulations that contain potent active ingredients in small amounts (thus often referred to as "bulking agents", "fillers", or "diluents"), o…- OSDF添加剤の世界市場（～2026年） OSDF excipients are chemical compounds that are added along with API and other chemicals during the manufacture of a drug. The global OSDF excipients market has been growing at a rapid pace. North America is leading the market, followed by APAC and Europe. Market Analysis and Insights: Global OSDF …
- 経口固形投与製剤の世界市場（～2026年） Oral solid dosage forms are the most commonly used pharmaceuticals to treat various disease conditions. Oral solid dosage forms are cost-effective and easy to manufacture in comparison with other dosage forms. They offer significant benefits to manufacturers such as trouble free packaging and transp…
- 製薬添加剤の世界市場（～2026年） Market Analysis and Insights: Global Pharma Excipients Market The global Pharma Excipients market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pharma Excipients Scope and Market Size Pharma Excipients market is segmented b…
- 包装・ラベリング（医療）サービスの世界市場（～2026年） This report on packaging and labeling (health care) services market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of packaging and labeling…